{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T21:52:47Z","timestamp":1792878767384,"version":"4.5.0"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Psychiatry Research"],"published-print":{"date-parts":[[2019,5]]},"DOI":"10.1016\/j.psychres.2019.01.110","type":"journal-article","created":{"date-parts":[[2019,3,19]],"date-time":"2019-03-19T18:23:38Z","timestamp":1553019818000},"page":"149-154","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":42,"special_numbering":"C","title":["Reasons for clozapine discontinuation in patients with treatment-resistant schizophrenia"],"prefix":"10.1016","volume":"275","author":[{"given":"Alp","family":"Ucok","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6825-2501","authenticated-orcid":false,"given":"Elif An\u0131l","family":"Ya\u011fc\u0131o\u011flu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0769-1628","authenticated-orcid":false,"given":"Mustafa","family":"Y\u0131ld\u0131z","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Semra Ulusoy","family":"Kaymak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meram Can","family":"Saka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2493-6351","authenticated-orcid":false,"given":"R\u00fcmeysa","family":"Ta\u015fdelen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ay\u015fen Esen","family":"Danac\u0131","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u015eevin Hun","family":"\u015eenol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.psychres.2019.01.110_bib0001","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.4088\/JCP.v68n0708","article-title":"Outcome following clozapine discontinuation: a retrospective analysis","volume":"68","author":"Atkinson","year":"2007","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.psychres.2019.01.110_bib0002","doi-asserted-by":"crossref","unstructured":"Beex-Oosterhuis M.M., Heerdink E.R.R., Van Gool A.R., van Marum R.J. Predicting unsuccessful clozapine treatment after first use in adult patients with psychotic disorders. J. Clin. Psychopharmacol. 38,604\u2013608.","DOI":"10.1097\/JCP.0000000000000977"},{"key":"10.1016\/j.psychres.2019.01.110_bib0004","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1111\/acps.12233","article-title":"Discontinuation of clozapine: a 15-year naturalistic retrospective study of 320 patients","volume":"130","author":"Davis","year":"2014","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.psychres.2019.01.110_bib0005","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1055\/s-0035-1554713","article-title":"Increasing clozapine dispensing trends in Queensland, Australia 2004\u20132013","volume":"48","author":"Forrester","year":"2015","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/j.psychres.2019.01.110_bib0006","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1177\/0269881118760666","article-title":"Long-term follow-up of clozapine prescribing","volume":"32","author":"Gee","year":"2018","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.psychres.2019.01.110_bib0008","first-page":"73","article-title":"Association of clozapine with seizures: a brief report involving 222 patients prescribed clozapine","volume":"25","author":"Grover","year":"2015","journal-title":"East Asian Arch. Psychiatry"},{"key":"10.1016\/j.psychres.2019.01.110_bib0009","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.eurpsy.2005.12.001","article-title":"Antipsychotic type and correlates of antipsychotic treatment discontinuation in the outpatient treatment of schizophrenia","volume":"21","author":"Haro","year":"2006","journal-title":"Eur. Psychiatry"},{"key":"10.1016\/j.psychres.2019.01.110_bib0010","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1192\/bjp.bp.111.105833","article-title":"Adherence to treatment guidelines in clinical practice: study of antipsychotic treatment prior to clozapine initiation","volume":"201","author":"Howes","year":"2012","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.psychres.2019.01.110_bib0011","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1176\/appi.ajp.2016.16050503","article-title":"Treatment-resistant schizophrenia: treatment response and resistance in psychosis (TRRIP) working group consensus guidelines on diagnosis and terminology","volume":"174","author":"Howes","year":"2017","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.psychres.2019.01.110_bib0012","doi-asserted-by":"crossref","first-page":"S961","DOI":"10.1016\/S0924-977X(17)31696-6","article-title":"A major challenge for clinicians:discussing rechallenge with clozapine through a case series. Abstracts of 30th European College of Neuropsychopharmacology Congress (ECNP)","volume":"27","author":"Hun \u015eenol","year":"2017","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.psychres.2019.01.110_bib0013","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1097\/JCP.0000000000000904","article-title":"Analysis of clozapine use and safety by using comprehensive national data from the Japanese clozapine patient monitoring service","volume":"38","author":"Inada","year":"2018","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.psychres.2019.01.110_bib0015","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1001\/archpsyc.1988.01800330013001","article-title":"Clozapine for the treatment-resistant schizophrenic. A double-blind comparison with chlorpromazine","volume":"45","author":"Kane","year":"1988","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.psychres.2019.01.110_bib0016","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1097\/YIC.0b013e32834ab34c","article-title":"Predictors of clozapine discontinuation in patients with schizophrenia","volume":"26","author":"Krivoy","year":"2011","journal-title":"Int. Clin. Psychopharmacol."},{"key":"10.1016\/j.psychres.2019.01.110_bib0017","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.schres.2016.05.002","article-title":"Reasons for discontinuing clozapine: a cohort study of patients commencing treatment","volume":"174","author":"Legge","year":"2016","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.psychres.2019.01.110_bib0018","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1056\/NEJMoa051688","article-title":"Effectiveness of antipsychotic drugs in patients with chronic schizophrenia","volume":"353","author":"Lieberman","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.psychres.2019.01.110_bib0019","doi-asserted-by":"crossref","first-page":"167","DOI":"10.3109\/10401239509149622","article-title":"Risk factors for clozapine discontinuation among 805 patients in the VA hospital system","volume":"7","author":"Moeller","year":"1995","journal-title":"Ann. Clin. Psychiatry"},{"key":"10.1016\/j.psychres.2019.01.110_bib0020","first-page":"11","article-title":"\"Schizophrenia past clozapine\": reasons for clozapine discontinuation, mortality, and alternative antipsychotic prescribing","volume":"48","author":"Mustafa","year":"2015","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/j.psychres.2019.01.110_bib0021","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1097\/JCP.0000000000000597","article-title":"Time-to-first discontinuation, adherence and persistence in new users of second-generation antipsychotics","volume":"36","author":"Ndukwe","year":"2016","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.psychres.2019.01.110_bib0022","doi-asserted-by":"crossref","first-page":"603","DOI":"10.4088\/JCP.12r08064","article-title":"Termination of clozapine treatment due to medical reasons: when is it warranted and how can it be avoided?","volume":"74","author":"Nielsen","year":"2013","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.psychres.2019.01.110_bib0023","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/j.1600-0447.2011.01776.x","article-title":"Reason for clozapine cessation","volume":"125","author":"Pai","year":"2012","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.psychres.2019.01.110_bib0024","first-page":"253","article-title":"The risk of suicide after clozapine discontinuation: cause for concern","volume":"27","author":"Patchan","year":"2015","journal-title":"Ann. Clin. Psychiatry"},{"key":"10.1016\/j.psychres.2019.01.110_bib0025","first-page":"1","article-title":"Systematic review of the efficacy and tolerability of clozapine in the treatment of youth with early onset schizophrenia","volume":"29","author":"Schneider","year":"2014","journal-title":"Eur. Psychiatry"},{"key":"10.1016\/j.psychres.2019.01.110_bib0026","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1177\/2045125317741449","article-title":"Clozapine discontinuation in early schizophrenia: a retrospective case note review of patients under an early intervention service","volume":"8","author":"Shaker","year":"2018","journal-title":"Ther. Adv. Psychopharmacol."},{"key":"10.1016\/j.psychres.2019.01.110_bib0027","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1192\/bjp.bp.115.177261","article-title":"Clozapine v. first- and second-generation antipsychotics in treatment-refractory schizophrenia: systematic review and meta-analysis","volume":"209","author":"Siskind","year":"2016","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.psychres.2019.01.110_bib0028","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1177\/0706743717718167","article-title":"Clozapine response rates among people with treatment-resistant schizophrenia: data from a systematic review and meta-analysis","volume":"62","author":"Siskind","year":"2017","journal-title":"Can. J. Psychiatry"},{"key":"10.1016\/j.psychres.2019.01.110_bib0030","doi-asserted-by":"crossref","first-page":"240","DOI":"10.4088\/JCP.v69n0210","article-title":"Comparing the use and discontinuation of antipsychotics in clinical practice: an observational study","volume":"69","author":"Taylor","year":"2008","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.psychres.2019.01.110_bib0031","doi-asserted-by":"crossref","unstructured":"Ucok A., \u00c7ikrik\u00e7ili U., Karabulut S., Salaj A., \u00d6zt\u00fcrk M., Tabak \u00d6., et\u00a0al. Delayed initiation of clozapine may be related to poor response in treatment-resistant schizophrenia. Int. Clin. Psychopharmacol. 30,290\u2013295.","DOI":"10.1097\/YIC.0000000000000086"},{"key":"10.1016\/j.psychres.2019.01.110_bib0032","series-title":"The Guideline for Treatment of Schizophrenia","author":"Ucok","year":"2010"}],"container-title":["Psychiatry Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165178118322947?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165178118322947?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T19:55:51Z","timestamp":1606852551000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165178118322947"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5]]},"references-count":28,"alternative-id":["S0165178118322947"],"URL":"https:\/\/doi.org\/10.1016\/j.psychres.2019.01.110","relation":{},"ISSN":["0165-1781"],"issn-type":[{"value":"0165-1781","type":"print"}],"subject":[],"published":{"date-parts":[[2019,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Reasons for clozapine discontinuation in patients with treatment-resistant schizophrenia","name":"articletitle","label":"Article Title"},{"value":"Psychiatry Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.psychres.2019.01.110","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}